Ultragenyx Pharmaceutical Inc at Jefferies Gene Therapy/Editing Summit Transcript
(Audio in progress) -- and I am one of the biotech analysts at Jefferies. It's with great pleasure that I'd like to introduce the CEO of Ultragenyx, Emil Kakkis. Thanks for coming to join us today, Emil. We are going to do a fireside chat, but Emil is going to do an introduction to Ultragenyx with a few slides and then we'll hop into the fireside chat.
Thanks, Maury. It's good to be here this morning. I won't go through the whole story of Ultragenyx, but I'll try to focus in on the gene therapy and some of the latest information. Here's our legal warning.
Now I will talk a little about the gene therapy pipeline which is at the bottom of the chart, but the top of the chart makes us distinct. Maybe -- BioMarin is another company was approved products and revenues from things other than gene therapy. We are a diversified company, not just a gene therapy company. We intend to stay as a diversified company.
Our gene therapy platform comes
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
